Community Health (CG5) Stock Forecast & Price Target

Compare

1 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

CG5 Analyst Ratings

Hold

2 Buy

4 Hold

2 Sell

Based on 8 analysts giving stock ratings to

Community

Health

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

CG5 Stock 12 Month Forecast

Average Price Target

€3.37

▲(19.60% Upside)

Based on 8 Wall Street analysts offering 12 month price targets for Community Health in the last 3 months. The average price target is €3.37 with a high forecast of €4.29 and a low forecast of €2.57. The average price target represents a 19.60% change from the last price of €2.82.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"1":"€1","6":"€6","2.25":"€2.25","3.5":"€3.5","4.75":"€4.75"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":4.29095415,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">€4.29</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":3.3726899619,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">€3.37</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":2.57457249,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">€2.57</span>\n  </div></div>","useHTML":true}}],"tickPositions":[1,2.25,3.5,4.75,6],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2025","6":"May<br/>2025","9":"Aug<br/>2025","12":"Nov<br/>2025","25":"Nov<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.3,3.3762272423076922,3.4524544846153846,3.528681726923077,3.604908969230769,3.6811362115384614,3.757363453846154,3.833590696153846,3.9098179384615386,3.9860451807692305,4.062272423076923,4.138499665384615,4.214726907692308,{"y":4.29095415,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.3,3.3055915355307692,3.311183071061538,3.3167746065923076,3.3223661421230766,3.327957677653846,3.3335492131846154,3.3391407487153844,3.3447322842461538,3.350323819776923,3.355915355307692,3.3615068908384615,3.3670984263692305,{"y":3.3726899619,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,3.3,3.244197883846154,3.1883957676923074,3.1325936515384614,3.0767915353846154,3.0209894192307694,2.965187303076923,2.909385186923077,2.853583070769231,2.7977809546153845,2.7419788384615384,2.6861767223076924,2.630374606153846,{"y":2.57457249,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":5.55,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.7,"date":1730419200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.22,"date":1733011200000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 13</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.84,"date":1735689600000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 14</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":3.1,"date":1738368000000,"info":" <span style=\"color:#912767\" class=\"mb3 mt2 fonth8_semibold\"> Strong Sell</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 5, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 7</span>\n      ","marker":{"lineColor":"#912767","enabled":true,"symbol":"circle"}},{"y":2.46,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.34,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.34,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.84,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.24,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 3,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.32,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 1</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":2.639,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":3.3,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Moderate Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 4,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 16, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target€4.29

Average Price Target€3.37

Lowest Price Target€2.57

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Stephen Baxter

Wells Fargo

€2.59

Sell

-8.12%

Downside

Reiterated

11/12/25

Wells Fargo Sticks to Their Sell Rating for Community Health (CYH)

John Ransom

Raymond James

―

Sell

―

Reiterated

10/28/25

Community Health (CYH) Gets a Sell from Raymond James

David S Macdonald

Truist Financial

€2.81→€3.89

Hold

37.82%

Upside

Reiterated

10/27/25

Community Health (CYH) Gets a Hold from Truist Financial

A.J. Rice

UBS

€2.76→€3.11

Hold

10.26%

Upside

Reiterated

10/27/25

Community Health price target raised to $3.60 from $3.20 at UBSCommunity Health price target raised to $3.60 from $3.20 at UBS

Ben Hendrix

RBC Capital

€4.32

Buy

53.14%

Upside

Reiterated

10/27/25

RBC Capital Reaffirms Their Buy Rating on Community Health (CYH)

Michael Wiederhorn

Oppenheimer

€3.45

Buy

22.51%

Upside

Reiterated

10/24/25

Oppenheimer Sticks to Its Buy Rating for Community Health (CYH)

Andrew Mok CFA

Barclays

€3.02

Hold

7.20%

Upside

Reiterated

10/24/25

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), Community Health (NYSE: CYH) and West Pharmaceutical Services (NYSE: WST)

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

10/24/25

Brian Tanquilut

Jefferies

€2.59

Hold

-8.12%

Downside

Downgraded

07/24/25

Community Health (CYH) Receives a Buy from Jefferies

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Stephen Baxter

Wells Fargo

€2.59

Sell

-8.12%

Downside

Reiterated

11/12/25

Wells Fargo Sticks to Their Sell Rating for Community Health (CYH)

John Ransom

Raymond James

―

Sell

―

Reiterated

10/28/25

Community Health (CYH) Gets a Sell from Raymond James

David S Macdonald

Truist Financial

€2.81→€3.89

Hold

37.82%

Upside

Reiterated

10/27/25

Community Health (CYH) Gets a Hold from Truist Financial

A.J. Rice

UBS

€2.76→€3.11

Hold

10.26%

Upside

Reiterated

10/27/25

Community Health price target raised to $3.60 from $3.20 at UBSCommunity Health price target raised to $3.60 from $3.20 at UBS

Ben Hendrix

RBC Capital

€4.32

Buy

53.14%

Upside

Reiterated

10/27/25

RBC Capital Reaffirms Their Buy Rating on Community Health (CYH)

Michael Wiederhorn

Oppenheimer

€3.45

Buy

22.51%

Upside

Reiterated

10/24/25

Oppenheimer Sticks to Its Buy Rating for Community Health (CYH)

Andrew Mok CFA

Barclays

€3.02

Hold

7.20%

Upside

Reiterated

10/24/25

Analysts Offer Insights on Healthcare Companies: Edwards Lifesciences (NYSE: EW), Community Health (NYSE: CYH) and West Pharmaceutical Services (NYSE: WST)

Jason Cassorla

Guggenheim

―

Hold

―

Reiterated

10/24/25

Brian Tanquilut

Jefferies

€2.59

Hold

-8.12%

Downside

Downgraded

07/24/25

Community Health (CYH) Receives a Buy from Jefferies

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Community Health

1 Month

xxx

Success Rate

12/21 ratings generated profit

Average Return

-0.36%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 57.14% of your transactions generating a profit, with an average return of -0.36% per trade.

3 Months

xxx

Success Rate

10/21 ratings generated profit

Average Return

-0.93%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 47.62% of your transactions generating a profit, with an average return of -0.93% per trade.

1 Year

Michael WiederhornOppenheimer

Success Rate

17/39 ratings generated profit

Average Return

+12.54%

reiterated a buy rating 2 months ago

Copying Michael Wiederhorn's trades and holding each position for 1 Year would result in 43.59% of your transactions generating a profit, with an average return of +12.54% per trade.

2 Years

xxx

Success Rate

14/39 ratings generated profit

Average Return

+4.89%

reiterated a xxx

rating 2 months ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 35.90% of your transactions generating a profit, with an average return of +4.89% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

CG5 Analyst Recommendation Trends

Rating

Jul 25

Aug 25

Sep 25

Oct 25

Nov 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, CG5 has received 4 Buy Ratings, 16 Hold Ratings, and 3 Sell Ratings. CG5 average Analyst price target in the past 3 months is 3.37.

Each month's total comprises the sum of three months' worth of ratings.

CG5 Financial Forecast

CG5 Earnings Forecast

Next quarter’s earnings estimate for CG5 is -€0.04 with a range of -€0.30 to €0.37. The previous quarter’s EPS was €1.09. CG5 beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.07% of the time in the same period. In the last calendar year CG5 has Performed in-line its overall industry.

CG5 Sales Forecast

Next quarter’s sales forecast for CG5 is €2.68B with a range of €2.66B to €2.70B. The previous quarter’s sales results were €2.64B. CG5 beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 47.62% of the time in the same period. In the last calendar year CG5 has Performed in-line its overall industry.

CG5 Stock Forecast FAQ

What is DE:CG5’s average 12-month price target, according to analysts?

Based on analyst ratings, Community Health’s 12-month average price target is 3.37.

What is DE:CG5’s upside potential, based on the analysts’ average price target?

Community Health has 19.60% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is Community Health a Buy, Sell or Hold?

Community Health has a consensus rating of Hold, which is based on 2 buy ratings, 4 hold ratings and 2 sell ratings.

What is Community Health’s share price target?

The average share price target for Community Health is 3.37. This is based on 8 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst share price target is €4.29 ,and the lowest forecast is €2.57. The average share price target represents 19.60% Increase from the current price of €2.82.

What do analysts say about Community Health?

Community Health’s analyst rating consensus is a Hold. This is based on the ratings of 8 Wall Streets Analysts.

How can I buy shares of Community Health?

To buy shares of DE:CG5, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.

Community Health (CG5) Stock Forecast & Price Target

CG5 Analyst Ratings

CG5 Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Community Health

CG5 Analyst Recommendation Trends

CG5 Financial Forecast

CG5 Earnings Forecast

CG5 Sales Forecast

CG5 Stock Forecast FAQ

Detailed List of Analyst Forecasts